QLINE
Q-Line Biotech Limited
NSEFiling History
Recent corporate announcements and filings for QLINE
Business Update
Neutral
2026-11-05 19:56
Concall Schedule
Concall Date: Friday, November 13, 2026
Concall Time: 12:30 P.M. IST
Governance
Neutral
2026-11-05 19:15
- Clarification issued regarding the Board Meeting scheduled for November 12, 2026.
- Correct meeting time clarified as 4:15 P.M. instead of 3:00 P.M. due to a clerical error.
- Board to consider and approve unaudited financial results for the half year ended September 30, 2026.
Routine
Neutral
2026-09-28 16:39
- Trading window closure for dealing in company securities begins October 01, 2026.
- Closure pertains to the declaration of Unaudited Financial Results for the half-year ended September 30, 2026.
- Window opens 48 hours after the declaration of financial results.
Business Update
Positive
2026-09-02 17:56
- Q-Line Biotech Limited entered into an Amended and Restated License Agreement with Boule Medical AB, Sweden.
- Key commercial benefit is a 25% reduction in license/royalty payable by Q-Line, effective from July 01, 2026.
- This is expected to enhance cost efficiency, competitiveness, market outreach, and long-term growth for Q-Line.
- The agreement has an initial term of 5 years, extendable for up to 5 more years.